Replies to post #212526 on Biotech Values

[DewDiligence]

ABT 2Q17 sales by business segment:

 
 Medical devices  39%  
 Nutrition        26%  
 Diagnostics      19%  
 Pharmaceuticals† 15%

64% of overall sales were ex-US.

†Ex-US branded generics.